 TEL AVIV, Israel and RALEIGH, NC, July 22, 2021 PRNewswire -- RedHill Biopharma Ltd. Nasdaq: RDHL RedHill or the Company, a specialty biopharmaceutical company, today announced that RedHill Biopharma Inc., AstraZeneca AB and AstraZeneca Pharmaceuticals LP AstraZeneca and Nektar Therapeutics have entered into a settlement and license agreement with Apotex, Inc. and Apotex Corp. Apotex resolving their patent litigation in the U.S. in response to Apotexs Abbreviated New Drug Application ANDA seeking approval by the US. 